SCHEMBL2473607

SCHEMBL2473607

NNC(=O)C1CCC(Oc2ccccc2F)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.50
LPAR5 Q9H1C0 1/20 0.50
HTR1A P08908 4/20 0.43
SLC6A2 P23975 4/20 0.43
GAA P10253 3/20 0.43
SLC6A3 Q01959 3/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.42
CTSB P07858 1/20 0.41
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
KAT2B Q92831 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2473606 1.00 LPAR1 (0.50) LPAR1LPAR5HTR1ASLC6A2GAA
SCHEMBL2474983 0.83 EPHX2 (0.46) SLC6A2GAASLC6A3HPGDPOLB
SCHEMBL2474986 0.83 EPHX2 (0.46) SLC6A2GAASLC6A3HPGDPOLB
SCHEMBL10148355 0.82 LPAR1 (0.57) LPAR1LPAR5HTR1ASLC6A2SLC6A3
SCHEMBL16506413 0.82 LPAR1 (0.57) LPAR1LPAR5HTR1ASLC6A2SLC6A3
SCHEMBL2473260 0.81 LPAR1 (0.51) LPAR1LPAR5HTR1ASLC6A2GAA
SCHEMBL2473263 0.81 LPAR1 (0.51) LPAR1LPAR5HTR1ASLC6A2GAA
SCHEMBL3331589 0.81 MEN1 (0.54) GAAALDH1A1HPGDRAB9A
SCHEMBL2477604 0.81 MEN1 (0.54) GAAALDH1A1HPGDRAB9A
SCHEMBL2474740 0.80 EPHX2 (0.44) GAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370441-B1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2013-09-11 EP disclosed
US-8461152-B2 Arylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2013-06-11 US disclosed
US-20120225865-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES SCHNIDER PATRICK (CH) 2012-09-06 US disclosed
US-8227458-B2 Arylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2012-07-24 US disclosed
EP-2370441-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-10-05 EP disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES HOFFMANN-LA ROCHE, INC. 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225865-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES AVPR1A, AVPR1B, AVPR2 LPAR1 1084/4885LPAR5 719/4885HTR1A 27/4885
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES AVPR1A, AVPR1B, AVPR2 LPAR1 1084/4885LPAR5 719/4885HTR1A 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.